Morphological Observation of the Cashmere Goat Fetal Fibroblasts after mTOR Kinase Inhibition with Combination of Fluorescent Dyes and Confocal Cell Imaging

Abstract:

The mammalian target of rapamycin（mTOR）is a kind of Ser/Thr kinase in mammalian cells. It can recruit and integrate input signals from nutrients, growth factors, energy and environmental stress to regulate cell growth and proliferation via different cellular processes. This study uses the fetal fibroblasts of Inner Mongolia Cashmere goat (Capra hircas) to prove that the mTOR plays a critical role in formation of the cell cytoskeleton structure. The mTOR kinase activity was inhibited in Inner Mongolia Cashmere goat fetal fibroblasts (GFb) after treatment with CCI-779 (temsirolimus), an mTOR specific inhibitor for 48 h. The results showed that GFb cells were sensitive to CCI-779. GFb cells morphology and its cytoskeleton structure changed under confocal laser scanning microscopy stained with the Fluorescent phalloidin (50µg/ml, Phalloidin-FITC5282) which combines with F-actin. In summary, mTOR signaling pathway was proved to be functional in GFb cells and acts as a key regulator to form cell structure. The Morphological results indicated that perhaps the synthesis of microfilament or organization of cytoskeleton was disrupted in GFb cells when mTOR was inhibited.

• Periodical: Advanced Materials Research (Volumes 343-344)
• Pages: 590-593
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.343-344.590
• Online since: September 2011
• Authors: Yan Liang, Xiao Jing Wang, Shu Yu Li, Cheberi Cheberi, Zhi Gang Wang, Dong Jun Liu
• Keywords: CCI-779 (Temsirolimus), Confocal, Goat Fetal Fibroblasts Image, mTOR

References

[1] Wullschleger S., Loewith R., Hall M.N., TOR signaling in growth and metabolism [J]. Cell, vol. 124, pp.471-484, (2006).

DOI: 10.1016/j.cell.2006.01.016

[2] Schmelzle T., Hall M.N., TOR, a central controller of cell growth [J]. Cell, vol. 103, pp.253-260, (2000).

DOI: 10.1016/s0092-8674(00)00117-3

[3] Shaw R.J., Cantley L.C., Ras, PI (3) K and mTOR Signalling Controls Tumour Cell Growth [J]. Nature, vol. 441, pp.424-430, (2006).

DOI: 10.1038/nature04869

[4] Ma W.W., Jimeno A Temsirolimus[J]. Drugs Today (Barc) , vol. 43, pp.659-669, (2007).

[5] Frost P., et al, In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model [J]. Blood, vol. 104, pp.4181-4187, (2004).

DOI: 10.1182/blood-2004-03-1153

[6] Teachey D.T., et al, The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL [J]. Blood, vol. 107, pp.1149-1155, (2006).

DOI: 10.1182/blood-2005-05-1935

[7] Gridelli C., Maione P., Rossi A., The potential role of mTOR inhibitors in non-small cell lung cancer[J]. Oncologist, vol. 13, pp.139-147, (2008).

DOI: 10.1634/theoncologist.2007-0171

[8] Wang Z.G., Wu Y.J., Shorgen, The mTOR signaling pathway and the regulation of cell growth [J]. Acta Biophysica Sinaca, vol. 22, pp.333-342, (2007).

[9] Hay N., Sonenberg N., Upstream and downstream of mTOR[J]. Genes. Dev, vol. 18, pp.1926-1945, (2004).

DOI: 10.1101/gad.1212704

[10] Proud C.G., The multifaceted role of mTOR in cellular stress responses [J]. DNA Repair (Amst), vol. 3, pp.927-934, (2004).

DOI: 10.1016/j.dnarep.2004.03.012

[11] Vollenbröker B., et al, mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes[J]. Am J Physiol Renal Physiol, vol. 296, no. 2, pp. F418-426, (2009).

DOI: 10.1152/ajprenal.90319.2008

[12] Berven L.A., Willard FS., Crouch MF., Role of the p.70 (S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res, vol. 296, no. 2, pp.183-195, (2004).

DOI: 10.1016/j.yexcr.2003.12.032

[13] Woolner S., Miller A.L., Bement W.M., Imaging the cytoskeleton in live Xenopus laevis embryos. Methods Mol Biol, vol. 586, pp.23-39, (2009).

DOI: 10.1007/978-1-60761-376-3_2